Exciting new ECMO technology awaits compelling scientific evidence for widespread use in adults with respiratory failure

Intensive Care Medicine

Volumn 38, Issue 2, 2012, Pages 186-188

  Morris, Alan H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROTRECOGIN; FLECAINIDE; INSULIN; PENICILLIN G; VITAMIN K GROUP;

ADULT RESPIRATORY DISTRESS SYNDROME; CLINICAL TRIAL (TOPIC); EDITORIAL; EXTRACORPOREAL OXYGENATION; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; PNEUMOCYSTIS PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; SCHIZOPHRENIA; SEPSIS;

EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84856695823     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-011-2440-9     Document Type: Editorial

References (17)

1. G MacLaren A Combes RH Bartlett 2011 Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era Intensive Care Med 10.1007/s00134-011-2439-2 22147116
2. P Forrest J Ratchford B Burns R Herkes A Jackson B Plunkett P Torzillo P Nair E Granger M Wilson R Pye 2011 Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience Intensive Care Med 37 824 830 21359610 10.1007/s00134-011-2158-8 1:STN:280:DC%2BC3MvhslGnsw%3D%3D
3. Noah MA, Peek GJ, Finney SJ, Griffiths MJ, Harrison DA, Grieve R, Sadique MZ, Sekhon JS, McAuley DF, Firmin RK, Harvey C, Cordingley JJ, Price S, Vuylsteke A, Jenkins DP, Noble DW, Bloomfield R, Walsh TS, Perkins GD, Menon D, Taylor BL, Rowan KM (2011) Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA 306(15):1659-1668
4. J Mortensen 1992 Intravascular oxygenator: a new alternative method for augmenting blood gas transfer in patients with acute respiratory failure Artif Organs 16 75 82 1300104 10.1111/j.1525-1594.1992.tb00271.x 1:STN:280: DyaK3s3js1CktQ%3D%3D
5. WM Zapol MT Snider JD Hill RJ Fallat RH Bartlett LH Edmunds AH Morris ECI Peirce AN Thomas HJ Proctor PA Drinker PC Pratt A Bagniewski RG Miller 1979 Extracorporeal membrane oxygenation in severe acute respiratory failure JAMA 242 2193 2196 490805 10.1001/jama.1979.03300200023016 1:STN:280: DyaL3c%2FivF2muw%3D%3D (Pubitemid 10195729)
6. A Morris C Wallace R Menlove T Clemmer JJ Orme L Weaver N Dean F Thomas T East M Suchyta E Beck M Bombino D Sittig S Böhm B Hoffmann H Becks N Pace S Butler J Pearl B Rasmusson 1994 Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for ARDS [erratum 1994;149(3, Pt 1):838, Letters to the editor 1995;151(1):255-256, 1995;151(4):1269-1270, and 1997;156(3):1016-1017] Am J Respir Crit Care Med 149 295 305 8306022 1:STN:280:DyaK2c7jvVGrtA%3D%3D (Pubitemid 24068971)
7. G MacLaren 2011 Evidence and experience in extracorporeal membrane oxygenation Chest 139 965 21467066 10.1378/chest.10-2729
8. L Gattinoni A Pesenti M Caspani A Pelizzola D Mascheroni R Marcolin G Iapichino M Langer A Agostoni T Kolobow D Melrose G Damia 1984 The role of total static lung compliance in the management of severe ARDS unresponsive to conventional treatment Intensive Care Med 10 121 126 6376584 10.1007/BF00265800 1:STN:280:DyaL2c3ktVKgtw%3D%3D (Pubitemid 14121519)
9. Peek G, Clemens F, Elbourne D, Firmin R, Hardy P, Hibbert C, Killer H, Mugford M, Thalanany M, Tiruvoipati R, Truesdale A, Wilson A (2006) CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv Res 6:163. doi: 10.1186/1472-6963-6-163
10. GJ Peek M Mugford R Tiruvoipati A Wilson E Allen MM Thalanany CL Hibbert A Truesdale F Clemens N Cooper RK Firmin D Elbourne 2009 Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial Lancet 374 1351 1363 19762075 10.1016/S0140-6736(09) 61069-2
11. AH Morris E Hirshberg RR Miller KD Statler RD Hite 2010 Counterpoint: efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1) Chest 138 778 781 20923797 10.1378/chest.10-1792
12. AH Morris E Hirshberg RR Miller KD Statler RD Hite RD Hite 2010 Rebuttal from Dr. Morris et al Chest 138 783 784 10.1378/chest.10-1794
13. Morris A (2006) The importance of protocol-directed patient management for research on lung-protective ventilation. In: Dreyfuss D, Saumon G, Hubamyr R (eds) Ventilator-induced lung injury. Taylor & Francis, New York, pp 537-610
14. J Doust CD Mar 2004 Why do doctors use treatments that do not work? BMJ 328 474 475 14988163 10.1136/bmj.328.7438.474 (Pubitemid 38293599)
15. FDA (2011) FDA drug safety communication: voluntary market withdrawal of Xigris [drotrecogin alfa (activated)] due to failure to show a survival benefit. Available via http://www.fda.gov/Drugs/DrugSafety/ucm277114.htm. Accessed 25 Oct 2011
16. Checkley W (2011) Extracorporeal membrane oxygenation as a first-line treatment strategy for ARDS. JAMA 306(15):1703-1704
17. R Bone 1986 Extracorporeal membrane oxygenation for acute respiratory failure (Editorial) JAMA 256 910 3735617 10.1001/jama.1986.03380070116032 1:STN:280:DyaL283ot1Srtw%3D%3D